🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

State Street SPDR S&P Biotech ETF

XBI
$169.55 +$10 (5.90%)
Market Cap: $10.92 B
Gurus Holding
4
Popularity Rank
#2336
% of Shares Held
3.93%
Net Activity (Q2 2026)
+$53.48 M

Guru Ownership Trend

Guru Analysis for State Street SPDR S&P Biotech ETF (XBI)

State Street SPDR S&P Biotech ETF (XBI), a key player in the Market sector, continues to attract institutional attention.

As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $451.77 M.

Top institutional holders include Jefferies Group and Paul Tudor Jones.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $53.48 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Jefferies Group reduced exposure by 7.6%.

Key Holders

Top 5 by Value

$338.66 M
$79.44 M
$3.55 M
$14,822

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$81.13 M
Total Buy Value
New Buys 2
Additions 1
-$27.65 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
3

FAQs for State Street SPDR S&P Biotech ETF (XBI)

Major holders include Jefferies Group ($338.66 M), Paul Tudor Jones ($79.44 M), Cliff Asness ($3.55 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.66 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $53.48 M, with 3 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited XBI. The total reported sell value was $27.65 M.

Yes, 2 managers opened new positions in XBI, and 1 increased their existing holdings. The total reported buy value was $81.13 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
2.23% Reduce -7.6% 2,140,001 $338.66 M Q2 2026
0.11% New Buy 502,000 $79.44 M Q2 2026
0.00% Add 89.2% 22,421 $3.55 M Q2 2026
0.00% New Buy 94 $14,822 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form